Just months after ending his tenure as chair of the medical device lobby group AdvaMed, Nadim Yared is the new chair of the Medical Device Innovation Consortium; a highly influential public-private partnership that has helped the US Food and Drug Administration develop new regulations.
Yared, who is also CEO of the small medical device company CVRx Inc., ended his tenure as chair of AdvaMed in April where the main issues he lobbied for were repeal of the 2.3% medical device excise tax and reimbursement hurdles. Over the next two years as chair of MDIC, his focus will turn more to regulations and the FDA’s regulatory pathway. (Also see "New AdvaMed Chair Lobo: Devices Has A Good Story To Tell" - In Vivo, 1 May, 2019.) (Also see "Diversity, More Advocacy Among Lobo’s Top Priorities As New AdvaMed Board Chair" - Medtech Insight, 5 Apr, 2019.)
“Since its inception, MDIC has worked to transform regulatory processes to deliver critical, innovative medical technologies in a timely manner to US patients who need them,” said Yared. “I am excited to take on this role as chairman of the board for MDIC and to work alongside fellow board members, MDIC leadership, and its membership as we deepen the organization’s commitment to bring together government, industry, and nonprofit partners to support timely, safe and cost-effective medical device innovation.”
Yared has been on MDIC’s board of directors since 2013 and succeeds Abiomed Inc. CEO Michael Minogue, who will stay on the board.
“Nadim has extensive experience in the medtech industry and has made significant contributions as a member of MDIC’s board of directors over the past six years,” said Pamela Goldberg, CEO of MDIC. “I look forward to working even more closely with Nadim as we continue to accelerate patient access to innovative medical technologies.”
While at AdvaMed, in addition to the device tax and reimbursement, Yared also highlighted issues specifically important to small companies like his that make up 80% of medical device firms in the US.
Goldberg only came on board as CEO at MDIC a year ago and has been focused on issues such as the National Evaluation System for health Technology Coordinating Center (NESTcc), which is being funded by the US FDA to develop a database to track medical devices over their lifespan to better understand their safety and efficacy. (Also see "New MDIC CEO Talks NEST, Case For Quality, CMS, And More" - Medtech Insight, 24 May, 2018.)